Exploiting the CRISPR-Cas9 gene-editing system for human cancers and immunotherapy

Afolabi, LO; Afolabi, MO; Sani, MM; Okunowo, WO; Yan, DH; Chen, L; Zhang, YO; Wan, XC

Wan, XC (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Biotechnol, Ctr Prot & Cell Based Drugs,Guangdong Immune Cell, Shenzhen 518055, Peoples R China.; Zhang, YO (corresponding author), Tsinghua Univ, Open FIESTA Ctr, Shenzhen 518055, Peoples R China.

CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2021; 10 (6):

Abstract

The discovery of clustered regularly interspaced short palindromic repeats and CRISPR-associated protein 9 (CRISPR-Cas9) technology has brought advanc......

Full Text Link